US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist
  • 6.420
  • +0.220+3.55%
Close Feb 19 16:00 ET
  • 6.420
  • 0.0000.00%
Post 16:05 ET
287.55MMarket Cap-11.89P/E (TTM)

About Y-mAbs Therapeutics Company

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Company Profile

SymbolYMAB
Company NameY-mAbs Therapeutics
Listing DateSep 21, 2018
Issue Price16.00
Founded2015
CEOMr. Michael Rossi
MarketNASDAQ
Employees100
Fiscal Year Ends12-31
Address230 Park Avenue,Suite 3350
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10169-0005
Phone1-646-885-8505
Websitehttp://www.ymabs.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael Rossi
  • Director, President and Chief Executive Officer
  • 3.11M
  • Joris Wiel Jan Wilms
  • Senior Vice President and Chief Operating Officer
  • --
  • Dr. Steen Lisby
  • Senior Vice President and Chief Scientific Officer
  • --
  • Thomas Gad
  • Vice Chairman of the Board and Chief Business Officer
  • 2.45M
  • Peter P. Pfreundschuh
  • Chief Financial Officer and Treasurer
  • --
  • Vignesh Rajah
  • Senior Vice President and Chief Medical Officer
  • --
  • Sue Smith
  • Senior Vice President and Chief Commercial Officer
  • 887.28K
  • Dr. Torben Lund-Hansen, PhD
  • Senior Vice President and Chief Technical Officer
  • --
  • Natalie Tucker
  • Senior Vice President, Radiopharmaceutical Business Head
  • --
  • Doug Gentilcore
  • Senior Vice President, Danyelza Business
  • --
  • Dr. James I. Healy, M.D.,PhD
  • Chairman of the Board
  • 184.31K
  • Dr. Mary A. Tagliaferri, M.D.
  • Director
  • --
  • Johan Wedell-Wedellsborg
  • Independent Director
  • 158.06K
  • Laura J. Hamill
  • Independent Director
  • 168.06K
  • David N. Gill
  • Independent Director
  • 180.56K
  • Dr. Ashutosh Tyagi, M.D.
  • Independent Director
  • 158.06K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WINDA
873001
+26.05%
Hangzhou Anysoft Information Technology
300571
+12.90%
Shenzhen Jame Technology Corp.,
300868
+11.68%
4
Mingyue Optical Lens
301101
+10.63%
5
Chongqing Vdl Electronics
301121
+10.49%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025